If you’re among the 92% or so of Americans yet to get a bivalent COVID-19 booster, here’s some news to consider. The Pfizer/BioNTech updated vaccine triggers a stronger immune response than a fourth dose of their original vaccine, the company says.
If you’re among the 92% or so of Americans yet to get a bivalent COVID-19 booster, here’s some news to consider. The Pfizer/BioNTech updated vaccine triggers a stronger immune response than a fourth dose of their original vaccine, the company says.